Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.34 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.34 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7035939 | 0.80 | — | — | |
| Methane SCHEMBL466523 | 0.78 | — | — | |
| SCHEMBL7035216 | 0.73 | — | — | |
| SCHEMBL7030359 | 0.72 | SLC6A2 (0.33) | ADRA1DADRA1B | |
| SCHEMBL7031775 | 0.72 | ALDH1A1 (0.33) | — | |
| SCHEMBL7039079 | 0.71 | — | — | |
| SCHEMBL27916417 | 0.70 | HTR1A (0.39) | HTR1AADRA1DADRA1BKCNA3 | |
| SCHEMBL7036707 | 0.69 | — | — | |
| Benzene SCHEMBL7033229 | 0.67 | — | — | |
| SCHEMBL28127207 | 0.66 | HTR1A (0.34) | HTR1AADRA1DADRA1BKCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9957388-B2 | Polybutylene terephthalate resin composition and molded article | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20150368459-A1 | POLYBUTYLENE TEREPHTHALATE RESIN COMPOSITION AND MOLDED ARTICLE | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2015-12-24 | — | — | US | disclosed |
| EP-2944673-A1 | POLYBUTYLENE TEREPHTHALATE RESIN COMPOSITION, AND MOLDED ARTICLE | Mitsubishi Engineering-Plastics Corporation (JP) | 2015-11-18 | — | — | EP | disclosed |
| EP-2520617-B1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | MITSUBISHI ENG PLASTICS CORP (JP) | 2015-03-25 | — | — | EP | disclosed |
| US-8865342-B2 | Polycarbonate resin composition and molded article | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-10-21 | — | — | US | disclosed |
| US-20120301766-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2012-11-29 | — | — | US | disclosed |
| EP-2520617-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | Mitsubishi Engineering-Plastics Corporation (JP) | 2012-11-07 | — | — | EP | disclosed |
| EP-2505613-A1 | COMPOSITION, CURED PRODUCT, AND ELECTRONIC DEVICE | JSR Corporation (JP) | 2012-10-03 | — | — | EP | disclosed |
| EP-2404969-A1 | AROMATIC POLYCARBONATE RESIN COMPOSITION, PROCESS FOR PRODUCING RESIN COMPOSITION, AND MOLDED ARTICLE | Mitsubishi Engineering- Plastics Corporation (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-20030065117-A1 | Modified silicone compound, process of producing the same, and cured object obtained therefrom | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2003-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065117-A1 | Modified silicone compound, process of producing the same, and cured object obtained therefrom | ORMDL3, SGMS1, HEATR1 | HTR1A 2541/4885ADRA1D 3295/4885ADRA1B 3909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.